Eskinazi D P
Immunol Lett. 1984;7(4):221-8. doi: 10.1016/0165-2478(84)90047-6.
The present report describes a new approach utilizing sequential polyethylene glycol 6000 (PEG) precipitations to isolate and analyze circulating immune complexes (IC). Two experimental systems were studied. First, IC were formed by adding labeled or unlabeled bovine serum albumin (BSA) to anti-BSA antiserum. Sequential precipitations with PEG concentrations ranging from 2 to 6.2 indicated that immunoglobulin (Ig) molecules were precipitated in all experimental and control sera tested. In contrast, optimal precipitations of IC (i.e., highest BSA/Ig ratio) were a function both of PEG concentration and of BSA/anti-BSA ratio (i.e., of IC size). Satisfactory IC purification was achieved by precipitation with appropriate PEG concentration followed by incubation with STaphylococcus aureus, Cowan I. Second, in preliminary experiments, the same procedure was applied to human sera. The findings paralleled those of the BSA/anti-BSA system. While PEG precipitated Ig in all sera tested, a potential antigen was found only in the most IC-positive serum, and only at the higher of the two PEG concentrations tested. From our data, we conclude that PEG concentrations needed to precipitate IC cannot be predetermined, as they are a function of the size and probably the nature of the IC studied. This limitation can be overcome by the systematic sequential precipitations which increase the chances of identifying antigens and decrease the risks of confusing antigen-antibody complexes and Ig aggregates.
本报告描述了一种利用连续聚乙二醇6000(PEG)沉淀法分离和分析循环免疫复合物(IC)的新方法。研究了两个实验系统。首先,通过向抗牛血清白蛋白(BSA)抗血清中添加标记或未标记的BSA来形成IC。用浓度范围为2%至6.2%的PEG进行连续沉淀表明,在所测试的所有实验血清和对照血清中,免疫球蛋白(Ig)分子均被沉淀。相比之下,IC的最佳沉淀(即最高的BSA/Ig比率)是PEG浓度和BSA/抗BSA比率(即IC大小)两者的函数。通过用适当浓度的PEG沉淀,随后与金黄色葡萄球菌Cowan I孵育,实现了IC的满意纯化。其次,在初步实验中,将相同的程序应用于人类血清。结果与BSA/抗BSA系统的结果相似。虽然PEG在所有测试血清中均沉淀了Ig,但仅在IC阳性最强的血清中,且仅在两个测试PEG浓度中较高的那个浓度下发现了潜在抗原。根据我们的数据,我们得出结论,沉淀IC所需的PEG浓度无法预先确定,因为它们是所研究IC大小以及可能性质的函数。通过系统的连续沉淀可以克服这一局限性,这种方法增加了识别抗原的机会,并降低了混淆抗原 - 抗体复合物和Ig聚集体的风险。